期刊文献+

清热解毒方对2型糖尿病患者血清炎症因子干预的临床研究 被引量:12

Clinical intervention research of Qingrejiedu fang for serum inflammatory factors in patients with type 2 diabetes
下载PDF
导出
摘要 目的探讨清热解毒方对2型糖尿病(T2DM)患者血清肿瘤坏死因子α(TNF-α)、白介素6(IL-6)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)、空腹血糖(FBG)及糖化血红蛋白(HbA1C)水平的干预作用。方法将134例T2DM患者随机分为试验组和对照组,试验组给予清热解毒合剂口服治疗,对照组采用盐酸二甲双胍口服治疗,两组疗程均为8周,治疗前后测定TNF-α、IL-6、FINS、HOMA-IR、FBG、HbA1C以及临床症状的变化。结果治疗后两组TNF-α、IL-6、FINS、HOMA-IR、FBG及HbA1C均明显下降,临床症状明显改善;其中试验组的TNF-α、IL-6降低较对照组更为显著(P<0.05),临床主要症状改善更为显著(P<0.05),两组患者FINS、HOMA-IR、FBG及HbA1C治疗前后比较,差异有统计学意义(P<0.05或P<0.01),组间比较差异无统计学意义(P>0.05)。结论清热解毒方可能通过调控炎症因子的水平,改善IR,起到降低血糖的作用。 Objective To explore the intervention effect of Qingrejiedu fang for the levels of tumor necrosis factor- α (TNF-α), interleukin-6(IL-6), fasting insulin(FINS),insulin resistance index homeostasis model assessment of insulin resistance(HOMA-IR),fasting blood-glucose(FBG)and glycosylated hemoglobin(HbA1C) in patients with type 2 diabetes(T2DM). Methods 134 patients with T2DM were randomly divided into test group and control group.The test group were treated by Qingrejiedu fang,while the control group were treated by metformin hydrochloride.The treatment period of two groups was 8 weeks.The levels of TNF-α ,IL-6,FINS,HOMA-IR,FBG,HbA1C and the changes of clinical symptoms were measured before and after treatment. Results The levels of TNF- α,IL-6,FINS,HOMA-IR,FBG and HbA1C were all markedly reduced and clinical symptoms improved significantly in two groups after treatment. Compared with control group,the levels reduce of TNF- αand IL-6 in test group was more significant(P 〈 0.05),and the main clinical symptoms improved more significantly(P 〈 0.05). There were significant differences in the levels of FINS,HOMA-IR,FBG and HbA1C of two groups between before and after treatment(P 〈 0.05 or P 〈0.01),while the differences were not statistically between two groups(P 〉 0.05). Conclusion Qingrejiedu fang has the effect of lowering blood sugar by regulating the levels of inflammatory factors and improving insulin resistance(IR) probably.
出处 《中国医药科学》 2013年第8期9-14,共6页 China Medicine And Pharmacy
基金 国家自然科学基金资助项目(30772799)
关键词 2型糖尿病 炎症因子 中医药疗法 清热解毒方 Type 2 diabetes Inflammation factors Therapy of TCM Qingrejiedu fang
  • 相关文献

参考文献19

二级参考文献86

  • 1卜石,杨文英,王昕,潘琳.脂毒性对大鼠胰岛细胞凋亡的作用[J].中华糖尿病杂志(1006-6187),2004,12(6):433-436. 被引量:32
  • 2贾得道.论中医经脉的实质[J].山西中医,1995,11(6):1-4. 被引量:6
  • 3范萍,刘秉文,方定志,张荣爵,刘宇,傅明德.内源性高甘油三酯血症存在胰岛素抵抗[J].中国动脉硬化杂志,1996,4(2):104-107. 被引量:10
  • 4宁光.胰岛β细胞功能异常在2型糖尿病发生中的重要性[J].中华内分泌代谢杂志,2003,19:5-7. 被引量:1
  • 5Butler AE, Janson J, Bonner-weir S, et al. β-cell apoptosis in human with type 2 diabetes. Diabetes, 2003,52 : 102-110. 被引量:1
  • 6Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 1993,74 :609-619. 被引量:1
  • 7Grumstein HS, James DE, Storlien LH, et al. Hyperinsulinemia suppresses glucose utilization in specific brain regions: in vivo studies using the euglycemic clamp in the rat [ J]. Endocrinology, 1985,116(2) :604-610. 被引量:1
  • 8Christian RM, Helena D, Nikolaj I, et al. Tumor necrosis factainhibits insulin' s stimulating effect on glucose uptake and endothelium dependent vasodilation in humans [ J ]. Circulation, 2003, 108 : 1815-1820. 被引量:1
  • 9Polonsky K S.The beta-cell in diabetes:from molecular genetics to clinical research[J].Diabetes,1995,44(6):705-717. 被引量:1
  • 10Kwon G,Corbett J A,Hauser S,et al.Evidence for involvement of the proteasome complex(26S)and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells[J].Diabetes,1998,47(4):583-591. 被引量:1

共引文献2446

同被引文献173

引证文献12

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部